ALX Oncology Inc. (ALXO)
NASDAQ: ALXO
· Real-Time Price · USD
0.64
-0.02 (-2.29%)
At close: Aug 15, 2025, 1:10 PM
13F Institute Ownership
Total Institutes of 86 in ALX Oncology reduced their positions with a decrease of 8 investors compared to the previous quarter. A reduction of 7.62M shares, as total invested capital declined by $47.68M with ownership percentage dropping from 77.94% to 62.69%.
Options Activity
Institutions are holding Calls/Puts contracts nearly balanced, indicating a neutral sentiment.
Put/Call 1.085
1.09
Call Flow 34,000
48%
Put Flow 36,900
52%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Venbio Partners LLC | 18.18% | 9.7M | +0.00% | 6.04M | 4.89% | May 15, 2025 |
| Redmile Group, LLC | 6.82% | 3.64M | -1.32% | 2.27M | 0.21% | May 15, 2025 |
| Tang Capital Management LLC | 5.92% | 3.16M | -4.2% | 1.97M | 0.11% | May 15, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.